Ruthenium complex nanoscale particle, preparation method and application thereof, and antitumor drug
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE SEVENTH AFFILIATED HOSPITAL SUN YAT SEN UNIV SHENZHEN
- Publication Date
- 2022-01-14
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of antitumor drugs, and in particular relates to a ruthenium complex nanoscale particle, a preparation method and application thereof, and an antitumor drug. Background technique
[0002] Cancer is one of the major diseases that kill human beings. At present, chemotherapy drugs are mainly used to treat cancer. However, because most of the current chemotherapy drugs have serious side effects and drug resistance, the treatment effect is not satisfactory. Therefore, it is urgent to develop new types of drugs. Chemotherapy drugs.
[0003] Metal ruthenium complexes have attracted widespread attention because of their good anti-tumor activity. Currently, four cases of metal ruthenium complexes have entered clinical research as anti-tumor agents, and two are in the process of clinical research. Although numerous ruthenium complexes such as Ru1, Ru2, Ru3, Ru4, etc. shown below have been reported to have anti-tumor ...